Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 5/2018

01-05-2018 | Original Article

The outcome and timing of death of 17,767 nosocomial bloodstream infections in acute care hospitals in Finland during 1999–2014

Authors: Keiju S. K. Kontula, Kirsi Skogberg, Jukka Ollgren, Asko Järvinen, Outi Lyytikäinen

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 5/2018

Login to get access

Abstract

Few studies covering all patient groups and specialties are available regarding the outcome of nosocomial bloodstream infections (BSI). We analyzed the role of patient characteristics and causative pathogens of nosocomial BSIs reported by the hospitals participating in national surveillance in Finland during 1999–2014, in terms of outcome, with particular interest in those leading to death within 2 days (i.e. early death). National nosocomial BSI surveillance was laboratory-based and hospital-wide. Data on nosocomial BSIs was collected by infection control nurses, and dates of death were obtained from the national population registry with linkage to national identity codes. A total of 17,767 nosocomial BSIs were identified; 557 BSIs (3%) were fatal within 2 days and 1150 (6%) within 1 week. The 1-month case fatality was 14% (2460 BSIs), and 23% of the deaths occurred within 2 days and 47% within 1 week. The patients who died early were older than those who survived > 28 days, and their BSIs were more often related to intensive care. Gram-positive bacteria caused over half of the BSIs of patients who survived, whereas gram-negative bacteria, especially Pseudomonas aeruginosa, caused more often BSIs of patients who died early, and fungi BSIs of patients who died within 1 week. A significant portion of patients with nosocomial BSIs died early, which underlines the importance of rapid recognition of BSI. Hospital-wide surveillance data of causative pathogens can be utilized when composing recommendations for empiric antimicrobial treatment in collaboration with clinicians, as well as when promoting infection prevention.
Literature
1.
go back to reference Rodríguez-Baño J, López-Prieto MD, Portillo MM, Retamar P, Natera C, Nuño E et al (2010) Epidemiology and clinical features of community-acquired, healthcare-associated and nosocomial bloodstream infections in tertiary-care and community hospitals. Clin Microbiol Infect 16:1408–1413CrossRefPubMed Rodríguez-Baño J, López-Prieto MD, Portillo MM, Retamar P, Natera C, Nuño E et al (2010) Epidemiology and clinical features of community-acquired, healthcare-associated and nosocomial bloodstream infections in tertiary-care and community hospitals. Clin Microbiol Infect 16:1408–1413CrossRefPubMed
2.
go back to reference Søgaard M, Nørgaard M, Dethlefsen C, Schønheyder HC (2011) Temporal changes in the incidence and 30-day mortality associated with bacteremia in hospitalized patients from 1992 through 2006: a population-based cohort study. Clin Infect Dis 52:61–69CrossRefPubMed Søgaard M, Nørgaard M, Dethlefsen C, Schønheyder HC (2011) Temporal changes in the incidence and 30-day mortality associated with bacteremia in hospitalized patients from 1992 through 2006: a population-based cohort study. Clin Infect Dis 52:61–69CrossRefPubMed
3.
go back to reference Lenz R, Leal JR, Church DL, Gregson DB, Ross T, Laupland KB (2012) The distinct category of healthcare associated bloodstream infections. BMC Infect Dis 12:85CrossRefPubMedPubMedCentral Lenz R, Leal JR, Church DL, Gregson DB, Ross T, Laupland KB (2012) The distinct category of healthcare associated bloodstream infections. BMC Infect Dis 12:85CrossRefPubMedPubMedCentral
4.
go back to reference Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB (2004) Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39:309–317CrossRefPubMed Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB (2004) Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39:309–317CrossRefPubMed
5.
go back to reference McDonald JR, Friedman ND, Stout JE, Sexton DJ, Kaye KS (2005) Risk factors for ineffective therapy in patients with bloodstream infection. Arch Intern Med 165:308–313CrossRefPubMed McDonald JR, Friedman ND, Stout JE, Sexton DJ, Kaye KS (2005) Risk factors for ineffective therapy in patients with bloodstream infection. Arch Intern Med 165:308–313CrossRefPubMed
6.
go back to reference Mitt P, Adamson V, Lõivukene K, Lang K, Telling K, Päro K et al (2009) Epidemiology of nosocomial bloodstream infections in Estonia. J Hosp Infect 71:365–370CrossRefPubMed Mitt P, Adamson V, Lõivukene K, Lang K, Telling K, Päro K et al (2009) Epidemiology of nosocomial bloodstream infections in Estonia. J Hosp Infect 71:365–370CrossRefPubMed
7.
go back to reference Vrijens F, Hulstaert F, Van de Sande S, Devriese S, Morales I, Parmentier Y (2010) Hospital-acquired, laboratory-confirmed bloodstream infections: linking national surveillance data to clinical and financial hospital data to estimate increased length of stay and healthcare costs. J Hosp Infect 75:158–162CrossRefPubMed Vrijens F, Hulstaert F, Van de Sande S, Devriese S, Morales I, Parmentier Y (2010) Hospital-acquired, laboratory-confirmed bloodstream infections: linking national surveillance data to clinical and financial hospital data to estimate increased length of stay and healthcare costs. J Hosp Infect 75:158–162CrossRefPubMed
8.
go back to reference Lyytikäinen O, Klemets P, Ruutu P, Kaijalainen T, Rantala M, Ollgren J et al (2007) Defining the population-based burden of nosocomial pneumococcal bacteremia. Arch Intern Med 167:1635–1640CrossRefPubMed Lyytikäinen O, Klemets P, Ruutu P, Kaijalainen T, Rantala M, Ollgren J et al (2007) Defining the population-based burden of nosocomial pneumococcal bacteremia. Arch Intern Med 167:1635–1640CrossRefPubMed
9.
go back to reference Rodríguez-Baño J, Picón E, Gijón P, Hernández JR, Cisneros JM, Peña C et al (2010) Risk factors and prognosis of nosocomial bloodstream infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli. J Clin Microbiol 48:1726–1731CrossRefPubMedPubMedCentral Rodríguez-Baño J, Picón E, Gijón P, Hernández JR, Cisneros JM, Peña C et al (2010) Risk factors and prognosis of nosocomial bloodstream infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli. J Clin Microbiol 48:1726–1731CrossRefPubMedPubMedCentral
10.
go back to reference Barrasa-Villar JI, Aibar-Remón C, Prieto-Andrés P, Mareca-Doñate R, Moliner-Lahoz J (2017) Impact on morbidity, mortality, and length of stay of hospital-acquired infections by resistant microorganisms. Clin Infect Dis 65:644–652CrossRefPubMed Barrasa-Villar JI, Aibar-Remón C, Prieto-Andrés P, Mareca-Doñate R, Moliner-Lahoz J (2017) Impact on morbidity, mortality, and length of stay of hospital-acquired infections by resistant microorganisms. Clin Infect Dis 65:644–652CrossRefPubMed
11.
go back to reference Åttman E, Aittoniemi J, Sinisalo M, Vuento R, Lyytikäinen O, Kärki T et al (2015) Etiology, clinical course and outcome of healthcare-associated bloodstream infections in patients with hematological malignancies: a retrospective study of 350 patients in a Finnish tertiary care hospital. Leuk Lymphoma 56:3370–3377CrossRefPubMed Åttman E, Aittoniemi J, Sinisalo M, Vuento R, Lyytikäinen O, Kärki T et al (2015) Etiology, clinical course and outcome of healthcare-associated bloodstream infections in patients with hematological malignancies: a retrospective study of 350 patients in a Finnish tertiary care hospital. Leuk Lymphoma 56:3370–3377CrossRefPubMed
12.
go back to reference Laupland KB, Gregson DB, Zygun DA, Doig CJ, Mortis G, Church DL (2004) Severe bloodstream infections: a population-based assessment. Crit Care Med 32:992–997CrossRefPubMed Laupland KB, Gregson DB, Zygun DA, Doig CJ, Mortis G, Church DL (2004) Severe bloodstream infections: a population-based assessment. Crit Care Med 32:992–997CrossRefPubMed
13.
go back to reference Lambert ML, Suetens C, Savey A, Palomar M, Hiesmayr M, Morales I et al (2011) Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study. Lancet Infect Dis 11:30–38CrossRefPubMed Lambert ML, Suetens C, Savey A, Palomar M, Hiesmayr M, Morales I et al (2011) Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study. Lancet Infect Dis 11:30–38CrossRefPubMed
14.
go back to reference Pedersen G, Schønheyder HC (1997) Patients with bacteremia dying before notification of positive blood cultures: a 3-year clinical study. Scand J Infect Dis 29:169–173CrossRefPubMed Pedersen G, Schønheyder HC (1997) Patients with bacteremia dying before notification of positive blood cultures: a 3-year clinical study. Scand J Infect Dis 29:169–173CrossRefPubMed
15.
go back to reference Laupland KB, Svenson LW, Gregson DB, Church DL (2011) Long-term mortality associated with community-onset bloodstream infection. Infection 39:405–410CrossRefPubMed Laupland KB, Svenson LW, Gregson DB, Church DL (2011) Long-term mortality associated with community-onset bloodstream infection. Infection 39:405–410CrossRefPubMed
16.
go back to reference Skogberg K, Lyytikäinen O, Ollgren J, Nuorti JP, Ruutu P (2012) Population-based burden of bloodstream infections in Finland. Clin Microbiol Infect 18:E170–E176CrossRefPubMed Skogberg K, Lyytikäinen O, Ollgren J, Nuorti JP, Ruutu P (2012) Population-based burden of bloodstream infections in Finland. Clin Microbiol Infect 18:E170–E176CrossRefPubMed
17.
go back to reference Lyytikäinen O, Lumio J, Sarkkinen H, Kolho E, Kostiala A, Ruutu P et al (2002) Nosocomial bloodstream infections in Finnish hospitals during 1999-2000. Clin Infect Dis 35:e14–e19CrossRefPubMed Lyytikäinen O, Lumio J, Sarkkinen H, Kolho E, Kostiala A, Ruutu P et al (2002) Nosocomial bloodstream infections in Finnish hospitals during 1999-2000. Clin Infect Dis 35:e14–e19CrossRefPubMed
18.
go back to reference Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM (1988) CDC definitions for nosocomial infections, 1988. Am J Infect Control 16:128–140CrossRefPubMed Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM (1988) CDC definitions for nosocomial infections, 1988. Am J Infect Control 16:128–140CrossRefPubMed
19.
go back to reference Kontula KS, Skogberg K, Ollgren J, Järvinen A, Lyytikäinen O (2016) Early deaths in bloodstream infections: a population-based case series. Infect Dis (Lond) 48:379–385CrossRef Kontula KS, Skogberg K, Ollgren J, Järvinen A, Lyytikäinen O (2016) Early deaths in bloodstream infections: a population-based case series. Infect Dis (Lond) 48:379–385CrossRef
20.
go back to reference Edmond MB, Wallace SE, McClish DK, Pfaller MA, Jones RN, Wenzel RP (1999) Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis 29:239–244CrossRefPubMed Edmond MB, Wallace SE, McClish DK, Pfaller MA, Jones RN, Wenzel RP (1999) Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis 29:239–244CrossRefPubMed
21.
go back to reference Diekema DJ, Beekmann SE, Chapin KC, Morel KA, Munson E, Doern GV (2003) Epidemiology and outcome of nosocomial and community-onset bloodstream infection. J Clin Microbiol 41:3655–3660CrossRefPubMedPubMedCentral Diekema DJ, Beekmann SE, Chapin KC, Morel KA, Munson E, Doern GV (2003) Epidemiology and outcome of nosocomial and community-onset bloodstream infection. J Clin Microbiol 41:3655–3660CrossRefPubMedPubMedCentral
22.
go back to reference Hoenigl M, Wagner J, Raggam RB, Prueller F, Prattes J, Eigl S et al (2014) Characteristics of hospital-acquired and community-onset blood stream infections, South-East Austria. PLoS One 9:e104702CrossRefPubMedPubMedCentral Hoenigl M, Wagner J, Raggam RB, Prueller F, Prattes J, Eigl S et al (2014) Characteristics of hospital-acquired and community-onset blood stream infections, South-East Austria. PLoS One 9:e104702CrossRefPubMedPubMedCentral
23.
go back to reference Micek ST, Lloyd AE, Ritchie DJ, Reichley RM, Fraser VJ, Kollef MH (2005) Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment. Antimicrob Agents Chemother 49:1306–1311CrossRefPubMedPubMedCentral Micek ST, Lloyd AE, Ritchie DJ, Reichley RM, Fraser VJ, Kollef MH (2005) Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment. Antimicrob Agents Chemother 49:1306–1311CrossRefPubMedPubMedCentral
24.
go back to reference Leibovici L, Shraga I, Drucker M, Konigsberger H, Samra Z, Pitlik SD (1998) The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med 244:379–386CrossRefPubMed Leibovici L, Shraga I, Drucker M, Konigsberger H, Samra Z, Pitlik SD (1998) The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med 244:379–386CrossRefPubMed
25.
go back to reference Poikonen E, Lyytikäinen O, Anttila VJ, Koivula I, Lumio J, Kotilainen P et al (2010) Secular trend in candidemia and the use of fluconazole in Finland, 2004-2007. BMC Infect Dis 10:312CrossRefPubMedPubMedCentral Poikonen E, Lyytikäinen O, Anttila VJ, Koivula I, Lumio J, Kotilainen P et al (2010) Secular trend in candidemia and the use of fluconazole in Finland, 2004-2007. BMC Infect Dis 10:312CrossRefPubMedPubMedCentral
26.
go back to reference Vallés J, Calbo E, Anoro E, Fontanals D, Xercavins M, Espejo E et al (2008) Bloodstream infections in adults: importance of healthcare-associated infections. J Inf Secur 56:27–34 Vallés J, Calbo E, Anoro E, Fontanals D, Xercavins M, Espejo E et al (2008) Bloodstream infections in adults: importance of healthcare-associated infections. J Inf Secur 56:27–34
Metadata
Title
The outcome and timing of death of 17,767 nosocomial bloodstream infections in acute care hospitals in Finland during 1999–2014
Authors
Keiju S. K. Kontula
Kirsi Skogberg
Jukka Ollgren
Asko Järvinen
Outi Lyytikäinen
Publication date
01-05-2018
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 5/2018
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-018-3211-0

Other articles of this Issue 5/2018

European Journal of Clinical Microbiology & Infectious Diseases 5/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.